Septerna
Small molecule therapeutics targeting G protein-coupled receptors
- Sector
- Biotech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Founded
- 2019
- Latest Form D
- $73.5M, Jul 2023
- Total capital
- $73.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $73.5M
- 1 Form D · last Jul 2023
- 39 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 40 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$73.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Abraham BassanDirectorNamed in SEC Form D filings
- Alan EzekowitzDirectorNamed in SEC Form D filings
- Elizabeth BhattExecutive OfficerNamed in SEC Form D filings
- Jake SimsonDirectorNamed in SEC Form D filings
- Jeffrey FinerExecutive Officer, DirectorNamed in SEC Form D filings
- Jeffrey TongDirectorNamed in SEC Form D filings
Show all 8 people
- Ran XiaoExecutive OfficerNamed in SEC Form D filings
- Samira ShaikhlyExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 40- PendingAgonists Of Parathyroid Hormone 1 And Incretin ReceptorsUSPTOApplication PCTUS2025056547
- PendingAgonists Of Parathyroid Hormone 1 And Incretin ReceptorsUSPTOApplication PCTUS2025055535
- PendingTshr Inhibitors And Methods Of Use ThereofUSPTOApplication PCTUS2025053474
Show all 40 patent records
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication PCTUS2025056547Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication PCTUS2025055535Pending
- Tshr Inhibitors And Methods Of Use ThereofApplication PCTUS2025053474Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63907676Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63907427Pending
- Diaminomethylene-containing Agonists Of The Parathyroid Hormone 1 ReceptorApplication PCTUS2025043325Pending
- Bicyclic Heteroaromatic Agonists Of The Parathyroid Hormone 1 ReceptorApplication PCTUS2025037643Pending
- Compounds, Compositions And Methods Of Use To Treat Hypoparathyroidism And OsteoporosisApplication 19148193Pending
- 3,4-DIHYDROQUINOLIN-2(1H)-ONE Inhibitors Of TshrApplication PCTUS2025031537Pending
- 3,4-DIHYDROQUINOLIN-2(1H)-ONE Inhibitors Of TshrApplication 63807181Pending
- Cycloalkyl- And Piperidinyl-containing Diaminomethylene PYRIMIDINE-2,4,6-TRIONE Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication PCTUS2025026104Pending
- Spirocycle-containing Diaminomethylene PYRIMIDINE-2,4,6-TRIONE Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication PCTUS2025026101Pending
- Agonists Of Parathyroid Hormone 1 And Incretin Receptors Comprising Substituted Or Modified Diaminomethylene PYRIMIDINE-2,4,6-TRIONESApplication PCTUS2025026106Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63793948Pending
- Diaminomethylene-containing Agonists Of The Parathyroid Hormone 1 ReceptorApplication PCTUS2025026094Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63793788Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63752522Pending
- Spirocycle-containing Diaminomethylene PYRIMIDINE-2,4,6-TRIONE Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63752529Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63724119Pending
- Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63721146Pending
- Cycloalkyl- And Piperidinyl-containing Diaminomethylene PYRIMIDINE-2,4,6-TRIONE Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63715068Pending
- TSHR Inhibitors and Methods of Use ThereofApplication 63715386Pending
- Spirocycle-containing Diaminomethylene PYRIMIDINE-2,4,6-TRIONE Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63706474Pending
- Agonists Of Parathyroid Hormone 1 And Incretin Receptors Comprising Substituted Or Modified Diaminomethylene PYRIMIDINE-2,4,6-TRIONESApplication 63706308Pending
- 3,4-DIHYDROQUINOLIN-2(1H)-ONE Inhibitors Of TshrApplication 63697053Pending
- Compounds, Compositions And Methods Of Use To Treat Hypoparathyroidism And OsteoporosisApplication 19123662Pending
- Substituted 3,4-DIHYDROQUINOLINONE Inhibitors Of TshrApplication 19099412Pending
- Diaminomethylene-containing Agonists Of The Parathyroid Hormone 1 ReceptorApplication 63686933Pending
- Bicyclic Heteroaromatic Agonists Of The Parathyroid Hormone 1 ReceptorApplication 63671974Pending
- 3,4-DIHYDROQUINOLIN-2(1H)-ONE Inhibitors Of TshrApplication 63654477Pending
- MRGPRX2 Inhibitors And Methods Of Use ThereofApplication PCTUS2024026430Pending
- Spirocycle-containing Diaminomethylene PYRIMIDINE-2,4,6-TRIONE Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63638019Pending
- Agonists Of Parathyroid Hormone 1 And Incretin Receptors Comprising Substituted Or Modified Diaminomethylene PYRIMIDINE-2,4,6-TRIONESApplication 63637989Pending
- Diaminomethylene-containing Agonists Of The Parathyroid Hormone 1 ReceptorApplication 63637999Pending
- Cycloalkyl- And Piperidinyl-containing Diaminomethylene PYRIMIDINE-2,4,6-TRIONE Agonists Of Parathyroid Hormone 1 And Incretin ReceptorsApplication 63638001Pending
- Compounds, Compositions And Methods Of Use To Treat Hypoparathyroidism And OsteoporosisApplication PCTUS2024011633Pending
- MRGPRX2 Inhibitors And Methods Of Use ThereofApplication 63614730Pending
- MRGPRX2 Inhibitors And Methods Of Use ThereofApplication 63546090Pending
- Compounds, Compositions And Methods Of Use To Treat Hypoparathyroidism And OsteoporosisApplication PCTUS2023035798Pending
- Compounds, Compositions And Methods Of Use To Treat Hypoparathyroidism And OsteoporosisApplication 63532181Pending
Related companies, and why
- Nocion Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Comanche BiopharmaSimilar federal contract value in Biotech · null in contracts
- Expansion TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Blueprint MedicinesSimilar federal contract value in Biotech · null in contracts
- Spark Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Kate TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .